$NNVC Gets Ready To Begin Clinical Trials To Defeat COVID, & To Prepare Vs. The Next Corona Pandemic
  • last year
NanoViricides Inc. is a pharmaceutical company specializing in the development of nanomedicine drugs for treating viral infections.

This biopharma company is creating a nanoviricides platform technology that it is using for drug development to treat viral infections. This technology employs a novel mechanism that acts on the virus particle to create highly effective, first-in-class antiviral medications. NanoViricides’s hard work is now culminating in bringing its first drug, NV-CoV-2, into clinical trials this May.
Recommended